Interaction of serum amyloid P component with hexanoyl bis(D-proline) (CPHPC)

Area of Science:

• Biochemistry
• Structural Biology
• Pharmacology

Background:

• Serum amyloid P component (SAP) is a pentameric human plasma protein.
• SAP interacts with bivalent ligands like CPHPC via D-proline groups in a calcium-dependent manner.
• Ligand binding leads to cooperative effects, enhancing affinity and forming stabilized decameric complexes.

Purpose of the Study:

• To elucidate the high-resolution structural details of the SAP-CPPHC interaction using X-ray crystallography with cadmium ions.
• To compare the conformational states of CPHPC in solution and when bound to SAP.
• To inform the therapeutic development of CPHPC for SAP depletion in amyloidosis.

Main Methods:

• X-ray crystallography of the SAP-CPPHC-cadmium complex.
• High-performance liquid chromatography (HPLC) for conformational analysis in solution.
• Comparison of X-ray data with solution-state data.

Main Results:

• Cadmium-mediated X-ray analysis provided higher resolution structural insights into the SAP-CPPHC interaction compared to calcium.
• Conformational isomers of CPHPC were identified in solution and in the protein-bound state.
• The study detailed the specific interactions and conformational preferences of CPHPC when bound to SAP.

Conclusions:

• High-resolution structural data of the SAP-CPPHC complex enhances understanding of ligand-protein interactions.
• Understanding CPHPC conformation is crucial for optimizing its efficacy in SAP depletion therapies.
• The findings support the continued development of CPHPC for treating amyloidosis and related conditions.